New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System
Authors
Keywords
-
Journal
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Volume 2023, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2023-07-13
DOI
10.1155/2023/3362391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation
- (2023) Alexander Breskin et al. EPIDEMIOLOGY
- Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone
- (2023) Cæcilie Leding et al. Infectious Diseases
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
- (2022) Lamiaa El-Shennawy et al. Nature Communications
- From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants
- (2022) Vasileios Papanikolaou et al. GENE
- Incidence and risk factors for hyperkalaemia in patients treated for COVID‐19 with nafamostat mesylate
- (2022) Kentaro Kodama et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection
- (2022) Luise Hassler et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
- (2022) Els Tobback et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
- (2022) Tom Domovitz et al. Microbiology Spectrum
- Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor
- (2022) Marianne R Perera et al. JOURNAL OF INFECTIOUS DISEASES
- FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
- (2022) Teresa Brevini et al. NATURE
- Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
- (2021) Emma C. Thomson et al. CELL
- Covid‐19 and liver cirrhosis: focus on the non‐classical renin‐angiotensin system and implications for therapy
- (2021) Giovanni Sansoè et al. HEPATOLOGY
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- Antihypertensive medications and COVID‐19 diagnosis and mortality: Population‐based case‐control analysis in the United Kingdom
- (2021) Emma Rezel‐Potts et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm
- (2021) Jinghe Zhang et al. Cellular & Molecular Immunology
- Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19
- (2021) Alexander Kutz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection
- (2021) Rohan Ameratunga et al. Expert Review of Clinical Immunology
- Design and Synthesis of Pyrazolone-based Compounds as Potent Blockers of SARS-CoV-2 Viral Entry into the Host Cells
- (2021) Vincent A. Obakachi et al. JOURNAL OF MOLECULAR STRUCTURE
- Angiotensin-(1-7)—A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic
- (2021) Samuel N. Heyman et al. Journal of Clinical Medicine
- Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
- (2021) Ikram Omar Osman et al. Frontiers in Immunology
- Divergent impacts of tocilizumab and colchicine in COVID‐19‐associated coagulopathy: the role of alpha‐defensins
- (2021) Suhair Abdeen et al. BRITISH JOURNAL OF HAEMATOLOGY
- ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations
- (2021) Vito S. Hernández et al. EXPERIMENTAL NEUROLOGY
- Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries
- (2021) Kaiming Wang et al. HYPERTENSION
- Alamandine: Potential Protective Effects in SARS-CoV-2 Patients
- (2021) Ava Soltani Hekmat et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Molnupiravir in COVID-19: A systematic review of literature
- (2021) Awadhesh Kumar Singh et al. Diabetes & Metabolic Syndrome-Clinical Research & Reviews
- COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission
- (2020) Jinyang Gu et al. GASTROENTEROLOGY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
- (2020) Yanxiao Han et al. ACS Nano
- Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications
- (2020) Zaid Abassi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- COVID-19, ACE2, and the cardiovascular consequences
- (2020) Andrew M. South et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
- (2020) Manar Mohammed El Tabaa et al. BIOCHEMICAL PHARMACOLOGY
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
- (2020) Liang Chen et al. CARDIOVASCULAR RESEARCH
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis
- (2020) Carlos J. Pirola et al. JOURNAL OF INFECTION
- Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
- (2020) Hao Cheng et al. JOURNAL OF MEDICAL VIROLOGY
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Plasma CRP level is positively associated with the severity of COVID-19
- (2020) Wei Chen et al. Annals of Clinical Microbiology and Antimicrobials
- Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
- (2020) Frank L van de Veerdonk et al. eLife
- Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
- (2020) Maria Elena Flacco et al. HEART
- ACE2 and COVID-19 and the resulting ARDS
- (2020) Xiaoqing Zhang et al. POSTGRADUATE MEDICAL JOURNAL
- Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
- (2020) Kui K. Chan et al. SCIENCE
- The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
- (2020) Zaid Abassi et al. Frontiers in Immunology
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Human recombinant soluble ACE2 in severe COVID-19
- (2020) Alexander Zoufaly et al. Lancet Respiratory Medicine
- The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing
- (2020) Gang Xu et al. Cell Discovery
- ACE2: from protection of liver disease to propagation of COVID-19
- (2020) Fiona J. Warner et al. CLINICAL SCIENCE
- Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
- (2020) Hasan Satış et al. CYTOKINE
- Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
- (2020) Ma’mon M. Hatmal et al. Cells
- The Renin-Angiotensin System: Going Beyond the Classical Paradigms
- (2019) Robson A. Souza Santos et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Nose to brain delivery
- (2019) Ijeoma Uchegbu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Counter-regulatory renin–angiotensin system in cardiovascular disease
- (2019) Maria Paz Ocaranza et al. Nature Reviews Cardiology
- Pathways of hepatic and renal damage through non‐classical activation of the renin‐angiotensin system in chronic liver disease
- (2019) Giovanni Sansoè et al. LIVER INTERNATIONAL
- A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension
- (2018) Anna R. Hemnes et al. EUROPEAN RESPIRATORY JOURNAL
- Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation
- (2018) Yuehua You et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Forward and Reverse Signaling Mediated by Transmembrane Tumor Necrosis Factor-Alpha and TNF Receptor 2: Potential Roles in an Immunosuppressive Tumor Microenvironment
- (2017) Yang Qu et al. Frontiers in Immunology
- Angiotensin(1–7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H 2 O 2 -activated NLRP3 inflammasome/IL-1β/Smad circuit
- (2016) Li-Li Zhang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
- (2016) Hongjing Gu et al. Scientific Reports
- Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data
- (2016) Giovanni Sansoè et al. PLoS One
- Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes
- (2015) Yang Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
- (2014) Penghui Yang et al. Scientific Reports
- Angiotensin II–Independent Angiotensin-(1–7) Formation in Rat Hippocampus
- (2013) Marilia G.A.G. Pereira et al. HYPERTENSION
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Is the renin–angiotensin system actually hypertensive?
- (2013) Etienne Bérard et al. PEDIATRIC NEPHROLOGY
- Multiple Mechanisms for the Action of Chymase Inhibitors
- (2012) Shinji Takai et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
- (2011) Roelie M Wösten-van Asperen et al. JOURNAL OF PATHOLOGY
- Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2
- (2009) Chandana B. Herath et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The role of angiotensin-converting enzyme inhibition in endotoxin-induced lung injury in rats*
- (2009) Arne P. Neyrinck et al. CRITICAL CARE MEDICINE
- Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice
- (2009) Christoph H. Österreicher et al. HEPATOLOGY
- Chymase-Dependent Conversion of Big Endothelin-1 in the Mouse in Vivo
- (2008) E. Simard et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started